isGWAS Showcased at ESHG2024 in Berlin

We are delighted to announce that bioXcelerate AI’s innovative work was showcased at the prestigious European Society of Human Genetics (ESHG) Conference in Berlin. The ESHG event is a key platform for geneticists from Europe and around the world to share breakthroughs and advancements in human genetics research.

At the conference, Dr. Heiko Runz, a scientific partner of bioXcelerate, presented our pioneering isGWAS solution—an ultra-high-throughput, scalable, and equitable platform for inferring genetic associations with disease. This groundbreaking in-silico genome-wide association (isGWAS) technique uses a cutting-edge statistical algorithm to transform the time-consuming nature of traditional GWAS into a process that takes mere minutes.

isGWAS enables researchers to examine whole-genome sequencing data from millions of individuals without the need for access to individual-level data. Its computational efficiency, paired with its scalability, accelerates discoveries in human genetics while maintaining equitable access to large-scale biobank data. Additionally, isGWAS supports biobank design by predicting disease associations for any sample size, helping to drive impactful insights across a wide range of studies.

By leveraging this innovative platform, bioXcelerate is empowering researchers to fast-track genetic research and drive impactful discoveries in the field of human genetics.

Contact us here to learn more about how isGWAS can support your research.